- Trials with a EudraCT protocol (172)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
172 result(s) found for: Blood Circulation.
Displaying page 1 of 9.
EudraCT Number: 2011-000203-41 | Sponsor Protocol Number: AC-052-391 | Start Date*: 2011-09-06 | |||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd. | |||||||||||||
Full Title: Multicenter, double-blind, placebo-controlled, randomized, prospective study of bosentan as adjunctive therapy to inhaled nitric oxide in the management of persistent pulmonary hypertension of the ... | |||||||||||||
Medical condition: Persistent Pulmonary Hypertension of the Newborn (PPHN) | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Not Authorised) CZ (Prematurely Ended) GB (Completed) FR (Ongoing) BE (Prematurely Ended) PL (Prematurely Ended) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016248-37 | Sponsor Protocol Number: A1481276 | Start Date*: 2010-07-15 | |||||||||||
Sponsor Name:Pfizer Ltd., Ramsgate Road, Sandwich, Kent. CT13 9NJ UNITED KINGDOM | |||||||||||||
Full Title: A SINGLE ARM SINGLE CENTRE STUDY TO INVESTIGATE SAFETY AND EFFICACY OF SILDENAFIL IN NEAR TERM AND TERM NEWBORNS WITH PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN (PPHN) | |||||||||||||
Medical condition: Persistent pulmonary hypertension of the newborn (PPHN) | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005651-17 | Sponsor Protocol Number: plexusogsirkulasjon | Start Date*: 2013-06-13 |
Sponsor Name:Oslo Universitetssykehus | ||
Full Title: Plexus brachialis block and circulation. Comparing effects on skin microcirculation and macro circulation of lidocain brachial plexus block with versus without epinephrine. | ||
Medical condition: human microcirculation and haemodynamic changes (macrosirculation) in healthy volunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004433-24 | Sponsor Protocol Number: 59498 | Start Date*: 2017-05-17 |
Sponsor Name:Leids Universitair Medisch Centrum | ||
Full Title: ACE inhibition in Fontan patients: its effect on body fluid regulation. | ||
Medical condition: Patients with univentricular hearts palliated by the Fontan procedure | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002619-24 | Sponsor Protocol Number: A1481316 | Start Date*: 2013-03-04 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A MULTI-CENTRE, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, TWO-ARMED, PARALLEL GROUP STUDY TO EVALUATE EFFICACY AND SAFETY OF IV SILDENAFIL IN THE TREATMENT OF NEONATES WITH PERSISTENT PULMONA... | |||||||||||||
Medical condition: Persistent pulmonary hypertension of the newborn | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) SE (Completed) ES (Prematurely Ended) AT (Completed) DE (Completed) NO (Completed) IT (Completed) NL (Completed) DK (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002126-90 | Sponsor Protocol Number: 2019/399/HP | Start Date*: 2021-03-09 | ||||||||||||||||
Sponsor Name:Direction de la Recherche Clinique et de l’Innovation – CHU de Rouen | ||||||||||||||||||
Full Title: Opioid-Free Anesthesia in Cardiac Surgery | ||||||||||||||||||
Medical condition: Patients undergoing cardiac surgery under extracorporeal circulation with at least one aorto-coronary bypass and the removal of at least one internal mammary artery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002988-16 | Sponsor Protocol Number: MINT-2014-01 | Start Date*: 2015-07-01 | |||||||||||
Sponsor Name:Royal College of Surgeons in Ireland | |||||||||||||
Full Title: The Use of Milrinone in Neonates with Persistent Pulmonary Hypertension of the Newborn: A Randomised Controlled Trial Pilot Study (MINT 1) | |||||||||||||
Medical condition: Persistent Pulmonary Hypertension of the Newborn | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001632-28 | Sponsor Protocol Number: GENTLE | Start Date*: 2023-10-24 |
Sponsor Name:Rijnstate | ||
Full Title: Ghrelin in anterior circulation stroke and EVT | ||
Medical condition: acute ischemic stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000177-39 | Sponsor Protocol Number: Linea7-2013/06-APPEAR | Start Date*: 2014-07-17 |
Sponsor Name:IRCCS Policlinico San Donato | ||
Full Title: Albumin vs. Plasma for PEdiAtric pRiming (APPEAR) trial | ||
Medical condition: Congenital cardiac diseases needing surgical correction requiring intervention with extracorporeal circulation | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-005922-82 | Sponsor Protocol Number: IVIO1.3 | Start Date*: 2022-01-13 | |||||||||||
Sponsor Name:Prehospital Emergency Medical Services, Central Denmark Region | |||||||||||||
Full Title: Intravenous vs. Intraosseous Vascular Access During Out-of-Hospital Cardiac Arrest - A Randomized Clinical Trial | |||||||||||||
Medical condition: Out-of-hospital cardiac arrest (OHCA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020329-42 | Sponsor Protocol Number: CORTISONE | Start Date*: 2010-01-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE | |||||||||||||
Full Title: EFFECTS OF PREVENTIVE TREATMENT WITH STEROIDS ON COAGULATION DYSFUNCTION INDUCED BY EXTRACORPOREAL CIRCULATION | |||||||||||||
Medical condition: All patients were candidates for cardiac surgery intervention in extracorporeal circulation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004291-21 | Sponsor Protocol Number: 33IC30_166855 | Start Date*: 2018-01-15 |
Sponsor Name:Insel Gruppe AG - Inselspital Universitätsklinik für Kardiologie | ||
Full Title: Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntricular size and function – a multi-center, double-blind, randomized, placebo-controlled clinical trial – SERVE Trial | ||
Medical condition: Adults with congenital heart disease (CHD) and a right ventricle (RV) in subaortic (systemic) position. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-001139-22 | Sponsor Protocol Number: POPH | Start Date*: 2011-06-29 | |||||||||||
Sponsor Name:Medizinische Universität Graz, Klin. Abteilung für Gastroenterologie und Hepatologie | |||||||||||||
Full Title: AMBRISENTAN FOR TREATMENT OF PORTOPULMONARY HYPERTENSION (POPH): A PILOT STUDY | |||||||||||||
Medical condition: Portopulmonary Hypertension (PoPH) and Hepatopulmonary Syndrome HPS are present in a considerable number of patients with compensated cirrhosis. Treatment of PoPH with ambrisentan is well tolerated... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002342-23 | Sponsor Protocol Number: 58166 | Start Date*: 2016-07-29 |
Sponsor Name:VU University Medical Center | ||
Full Title: The cardiovascular dose-response to supplemental oxygen in healthy volunteers | ||
Medical condition: Healthy cardiovascular system | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003387-46 | Sponsor Protocol Number: COCA2 | Start Date*: 2019-10-28 | |||||||||||
Sponsor Name:Research Center for Emergency Medicine Department of Clinical Medicine Aarhus University | |||||||||||||
Full Title: Calcium for Out-of-Hospital Cardiac Arrest – A Randomized, Double-Blind, Placebo-Controlled trial | |||||||||||||
Medical condition: The study will include patients with out-of-hospital cardiac arrest (OHCA). The study will test whether treatment with Calcium Chloride added to standard care will improve survival following OHCA. ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014534-15 | Sponsor Protocol Number: NACIPP | Start Date*: 2009-10-01 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: EFFECT OF ACUTE ADMINISTRATION OF N-ACETYLCYSTEINE ON BLOOD PRESSURE OF PULMONARY ARTERIAL IN PRIMARY PULMONARY HYPERTENSION. | |||||||||||||
Medical condition: PRIMARY PULMONARY HYPERTENSION | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001723-19 | Sponsor Protocol Number: EC001(MenC1) | Start Date*: 2006-06-02 |
Sponsor Name:University of Bristol | ||
Full Title: AN OPEN LABEL, SINGLE CENTRE PILOT STUDY TO EVALUATE THE KINETICS OF THE SYSTEMIC B-CELL IMMUNE RESPONSE TO A MENINGOCOCCAL SEROGROUP C CONJUGATE VACCINE IN HEALTHY ADULTS | ||
Medical condition: Meningococcal serogroup C infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-020377-16 | Sponsor Protocol Number: ATIII | Start Date*: 2009-11-20 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE | |||||||||||||
Full Title: EFFECTS OF THE ADMINISTRATION OF ANTITHROMBIN ON THE EMOCOAGULATIVE STATE AND ON THE INFLAMMATORY RESPONSE IN PATIENT WITH LOW PLASMATIC LEVELS OF ANTITHROMBIN AFTER CARDIAC INTERVENTIONS | |||||||||||||
Medical condition: Patients candidates for cardiac surgery intervention in extracorporeal circulation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004169-14 | Sponsor Protocol Number: BMS-MB102-210 | Start Date*: 2014-02-07 | |||||||||||
Sponsor Name:University Hospital Erlangen | |||||||||||||
Full Title: Randomized, placebo controlled, crossover clinical study to analyse the effect of dapagliflozin on microvascular and macrovascular circulation and total body sodium content | |||||||||||||
Medical condition: Type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002638-36 | Sponsor Protocol Number: 1aa | Start Date*: 2020-03-03 |
Sponsor Name:Bispebjerg Hospital, University of Copenhagen | ||
Full Title: Glucagon Dose-response Relationship for Cardiovascular Activity A Randomized, participant-blinded, Crossover Study | ||
Medical condition: Glucagon-induced changes in heart rate, blood pressure, cardiac output. and metabolic effects | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.